Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Guardant Health, Inc. (GH) Profit Margins

Over the twelve months to 2026-06-30, Guardant Health, Inc. (GH) had gross margin 65.0%, operating margin -39.7%, net margin -38.3%, free cash flow margin -20.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GHGuardant Health, Inc.Follow GH — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
22.7B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin————59.7%60.8%64.5%65.0%
Operating margin-38.4%-88.9%-110.0%-121.1%-100.1%-60.0%-44.5%-39.7%
Net margin-35.3%-85.9%-103.0%-145.6%-85.0%-59.0%-42.4%-38.3%
FCF margin-30.7%-48.9%-76.0%-86.1%-61.3%-37.2%-23.7%-20.3%

USD billions · SEC XBRL

Guardant Health, Inc. — questions

What is Guardant Health, Inc.'s gross margin?
65.0% over the twelve months to 2026-06-30.
What is Guardant Health, Inc.'s operating margin?
-39.7% over the twelve months to 2026-06-30.
What is Guardant Health, Inc.'s net profit margin?
-38.3% over the twelve months to 2026-06-30.

Every figure on this page comes from Guardant Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.